Luigi Ruffo Codecasa

Amikacin Liposome Inhalation Suspension for Treatment-Refractory Lung Disease Caused by <i>Mycobacterium avium</i> Complex (CONVERT). A Prospective, Open-Label, Randomized Study

David E. Griffith, Gina Eagle, Rachel Thomson et al. · American Journal of Respiratory and Critical Care Medicine · 2018 · 343 citations

Medicine, Infectious Diseases, Pharmacology +17

Effectiveness and safety of bedaquiline-containing regimens in the treatment of MDR- and XDR-TB: a multicentre study

Borisov Se, Keertan Dheda, Martin Enwerem et al. · European Respiratory Journal · 2017 · 302 citations · Full text

Pharmacy, Infectious Diseases, Pharmacotherapy +16

Worldwide Effects of Coronavirus Disease Pandemic on Tuberculosis Services, January–April 2020

Giovanni Battista Migliori, Pei Min Thong, Onno W. Akkerman et al. · Emerging infectious diseases · 2020 · 222 citations · Full text

Public Health, Infectious Diseases, Global Health +8

Clinical and operational value of the extensively drug-resistant tuberculosis definition

Giovanni Battista Migliori, Giorgio Besozzi, Enrico Girardi et al. · European Respiratory Journal · 2007 · 195 citations · Full text

Public Health, Pharmacology, Pharmacotherapy +15

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

Borisov Se, Edvardas Danila, Andrei Maryandyshev et al. · European Respiratory Journal · 2019 · 177 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17